NDC 33342-132

Candesartan Cilexetil and Hydrochlorothiazide

Candesartan Cilexetil And Hydrochlorothiazide

Candesartan Cilexetil and Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Candesartan Cilexetil; Hydrochlorothiazide.

Product ID33342-132_66ca941e-6590-41a6-8d8f-caa2013089d0
NDC33342-132
Product TypeHuman Prescription Drug
Proprietary NameCandesartan Cilexetil and Hydrochlorothiazide
Generic NameCandesartan Cilexetil And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-03-07
Marketing CategoryANDA / ANDA
Application NumberANDA204100
Labeler NameMacleods Pharmaceuticals Limited
Substance NameCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active Ingredient Strength32 mg/1; mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 33342-132-10

90 TABLET in 1 BOTTLE (33342-132-10)
Marketing Start Date2015-03-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 33342-132-51 [33342013251]

Candesartan Cilexetil and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA204100
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-07

NDC 33342-132-12 [33342013212]

Candesartan Cilexetil and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA204100
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-07

NDC 33342-132-15 [33342013215]

Candesartan Cilexetil and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA204100
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-03-07

NDC 33342-132-10 [33342013210]

Candesartan Cilexetil and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA204100
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-03-07

Drug Details

Active Ingredients

IngredientStrength
CANDESARTAN CILEXETIL32 mg/1

OpenFDA Data

SPL SET ID:76630807-9717-44be-946d-756038cf677e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 578330
  • 578325
  • 802749
    • UPC Code
  • 0333342133106
  • 0333342132512
  • 0333342132109
  • 0333342133519
  • 0333342131515

    • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    Medicade Reported Pricing

    33342013215 CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB

    Pricing Unit: EA | Drug Type:

    33342013210 CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Candesartan Cilexetil and Hydrochlorothiazide" or generic name "Candesartan Cilexetil And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0378-3001Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3002Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3003Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    33342-131Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-132Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-133Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    43547-459candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-460candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-461candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    62559-660Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-661Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-662Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    68382-194candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    68382-416candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    68382-195candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1326candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1325candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70771-1327candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    70518-2720Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    0186-0162ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    0186-0322ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    62559-650ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-651ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-652ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.